Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11981671 Bicyclic pyrazolyl amines as CDK2 inhibitors

Patent 11981671 was granted and assigned to Incyte on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Liangxing Wu0

Joshua Hummel0

Ding-Quan Qian0

Jingwei Li0

Date of Patent

May 14, 2024

0

Patent Application Number

178451420

Date Filed

June 21, 2022

0

Patent Citations

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

0

US Patent 8168757 PD-1 binding proteins

0

US Patent 8183242 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof

0

US Patent 8217149 Anti-PD-L1 antibodies, compositions and articles of manufacture

0

US Patent 8431596 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use

0

US Patent 8865732 Heterocyclic compounds and uses thereof

0

US Patent 9073927 Inhibitors of PI3 kinase

0

US Patent 9850244 Method for preparing Palbociclib

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11981671 Bicyclic pyrazolyl amines as CDK2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool